Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.
Cholangiocarcinoma (CCA), a lethal disease, affects many thousands worldwide yearly. Surgical resection provides the best chance for a cure; however, only one-third of CCA patients present with a resectable tumour at the time of diagnosis. Currently, no effective chemotherapy is available for advanc...
Main Authors: | Chun-Nan Yeh, Kun-Chun Chiang, Horng-Heng Juang, Jong-Hwei S Pang, Chung-Shan Yu, Kun-Ju Lin, Ta-Sen Yeh, Yi-Yin Jan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3724720?pdf=render |
Similar Items
-
Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence
by: Kun-Ming Chan, et al.
Published: (2018-12-01) -
Hepatectomy or/with Metastatectomy for Recurrent Intrahepatic Cholangiocarcinoma: Of Promise for Selected Patients
by: Chun-Yi Tsai, et al.
Published: (2022-03-01) -
Opisthorchiasis, hypercholesterolemia, and cholangiocarcinoma: A reappraisal
by: Beuy Joob, et al.
Published: (2017-01-01) -
Topoisomerase inhibitors modulate gene expression of B-cell translocation gene 2 and prostate specific antigen in prostate carcinoma cells.
by: Kun-Chun Chiang, et al.
Published: (2014-01-01) -
The Emerging Role of MicroRNAs in Regulating the Drug Response of Cholangiocarcinoma
by: Wen-Kuan Huang, et al.
Published: (2020-09-01)